Cross Icon
Cross Icon

Levocabastine 0.05% Nasal Spray 10ml Tender - 76256718

The KING FAHD MEDICAL COMPLEX HOSPITAL IN DHAHRAN has issued a Tender notice for the procurement of a Levocabastine 0.05% Nasal Spray 10ml in the Saudi Arabia. This Tender notice was published on 16 Dec 2022 and is scheduled to close on 27 Dec 2022, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 76256718, while the tender notice number is M19-301974 and Registering on the platform.

Expired Tender

Procurement Summary

Country: Saudi Arabia

Summary: Levocabastine 0.05% Nasal Spray 10ml

Deadline: 27 Dec 2022

Posting Date: 16 Dec 2022

Other Information

Notice Type: Tender

TOT Ref.No.: 76256718

Document Ref. No.: M19-301974

Competition: NCB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

LEVOCABASTINE 0.05% NASAL SPRAY 10ML
The purpose of competition: Levocabastine 0.05% Nasal Spra Levocabastine 0.05% Nasal Spray 10ml.

The value of competition documents: 200.00 riyals

Reference number: 221239850792

Competition number: M19-301974

Competition type: Direct purchase

Competition case: accredited

Place of implementation: inside the Kingdom

Documents

 Tender Notice


Request Demo
GiZ Tenders India

Procurement Documents for Saudi Arabia

Access a comprehensive library of standard procurement documents specific to Saudi Arabia. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Saudi Arabia

Explore Procurement Documents for Saudi Arabia


Want To Bid in This Tender?

Get Local Agent Support in Saudi Arabia and 60 More Countries.

View All The Services


View Tenders By


Publish Tenders


Have Any Dispute With The Purchaser?